4.7 Article

MeCP2 Phosphorylation Is Required for Modulating Synaptic Scaling through mGluR5

Journal

JOURNAL OF NEUROSCIENCE
Volume 32, Issue 37, Pages 12841-12847

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2784-12.2012

Keywords

-

Categories

Funding

  1. NIH-NICHD [R01 HD064743, P30 HD03352]
  2. Stem Cell and Regenerative Medicine Center at the University of Wisconsin-Madison

Ask authors/readers for more resources

MeCP2 (methyl CpG binding protein 2) is a key player in recognizing methylated DNA and interpreting the epigenetic information encoded in different DNA methylation patterns. The functional significance of MeCP2 to the mammalian nervous system is highlighted by the discovery that mutations in the MECP2 gene cause Rett syndrome (RTT), a devastating neurological disease that shares many features with autism. Synaptic scaling is a form of non-Hebbian homeostatic plasticity that allows neurons to regulate overall excitability in response to changes in network neuronal activity levels. While it is known that neuronal activity can induce phosphorylation of MeCP2 and that MeCP2 can regulate synaptic scaling, the molecular link between MeCP2 phosphorylation and synaptic scaling remains undefined. We show here that MeCP2 phosphorylation is specifically required for bicuculline-induced synaptic scaling down in mouse hippocampal neurons and this phenotype is mediated by mGluR5 (metabotropic glutamate receptor 5). Our results reveal an important function of MeCP2 in regulating neuronal homeostasis and may eventually help us understand how MECP2 mutations cause RTT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available